{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:09Z","timestamp":1792143849934,"version":"4.4.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIA AG062222"],"award-info":[{"award-number":["NIA AG062222"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"DOI":"10.1186\/s40035-026-00593-x","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:45:28Z","timestamp":1792140328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhan","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa A.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Videlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel T.","family":"Maidment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"593_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103599","volume":"392","author":"LD Fricker","year":"2025","unstructured":"Fricker LD, Fakira AK, Bobeck EN, Raddatz M, Kim K, DeSchepper KD, et al. ProSAAS neuropeptides and receptors GPR171 and GPR83: potential therapeutic applications for pain, anxiety, and body weight regulation. J Pharmacol Exp Ther. 2025;392:103599.","journal-title":"J Pharmacol Exp Ther"},{"key":"593_CR2","doi-asserted-by":"publisher","first-page":"E4708","DOI":"10.1073\/pnas.1601091113","volume":"113","author":"TS Jarvela","year":"2016","unstructured":"Jarvela TS, Lam HA, Helwig M, Lorenzen N, Otzen DE, McLean PJ, et al. The neural chaperone proSAAS blocks \u03b1-synuclein fibrillation and neurotoxicity. Proc Natl Acad Sci U S A. 2016;113:E4708-15.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"593_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59414-4","volume":"10","author":"MS Rotunno","year":"2020","unstructured":"Rotunno MS, Lane M, Zhang W, Wolf P, Oliva P, Viel C, et al. Cerebrospinal fluid proteomics implicates the granin family in Parkinson\u2019s disease. Sci Rep. 2020;10:2479.","journal-title":"Sci Rep"},{"issue":"1","key":"593_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s43856-023-00294-w","volume":"3","author":"M Hadisurya","year":"2023","unstructured":"Hadisurya M, Li L, Kuwaranancharoen K, Wu X, Lee Z-C, Alcalay RN, et al. Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson\u2019s disease. Commun Med (Lond). 2023;3:64.","journal-title":"Commun Med (Lond)"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3233\/JPD-213053","volume":"12","author":"I Lindberg","year":"2022","unstructured":"Lindberg I, Shu Z, Lam H, Helwig M, Yucer N, Laperle A, et al. The proSAAS chaperone provides neuroprotection and attenuates transsynaptic \u03b1-synuclein spread in rodent models of Parkinson\u2019s disease. J Parkinsons Dis. 2022;12:1463\u201378.","journal-title":"J Parkinsons Dis"},{"key":"593_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue L-F, Adler CH, Shill HA, Caviness JN, Sabbagh MN, et al. Changes in properties of serine 129 phosphorylated \u03b1\u2010synuclein with progression of Lewy\u2010type histopathology in human brains. Exp Neurol. 2013;240:190\u2013204.","journal-title":"Exp Neurol"},{"issue":"1","key":"593_CR7","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z, et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun. 2022;13:5512.","journal-title":"Nat Commun"},{"key":"593_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"593_CR9","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1038\/s41467-021-26135-9","volume":"12","author":"Y Fujiwara","year":"2021","unstructured":"Fujiwara Y, Torphy RJ, Sun Y, Miller EN, Ho F, Borcherding N, et al. The GPR171 pathway suppresses T cell activation and limits antitumor immunity. Nat Commun. 2021;12:5857.","journal-title":"Nat Commun"},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1111\/jnc.16193","volume":"168","author":"S Mitias","year":"2024","unstructured":"Mitias S, Schaffer N, Nair S, Hook C, Lindberg I. ProSAAS is preferentially up-regulated during homeostatic scaling and reduces amyloid plaque burden in the 5xFAD mouse hippocampus. J Neurochem. 2024;168:3235\u201349.","journal-title":"J Neurochem"},{"key":"593_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/acschemneuro.2c00156","volume":"13","author":"JR Peinado","year":"2022","unstructured":"Peinado JR, Chaplot K, Jarvela TS, Barbieri EM, Shorter J, Lindberg I. Sequestration of TDP-43216-414 aggregates by cytoplasmic expression of the proSAAS chaperone. ACS Chem Neurosci. 2022;13:1651\u201365.","journal-title":"ACS Chem Neurosci"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00593-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:45:29Z","timestamp":1792140329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00593-x","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the UCLA Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"55"}}